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Summary (<125 words): Routine discharge at day 1 is possible after RARP. Improving the 
management of PONV may even allow outpatient management.  
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Abstract 
Objectives: To evaluate the feasibility of routine outpatient management after robotic-
assisted radical prostatectomy (RARP). Prostate cancer is indeed the second most common 
cancer in men. Surgical technics have evolved from open surgery to robot-assisted surgery 
with a reduction of postoperative complications. Such technical improvements associated 
with modern anesthesia allow outpatient surgery in various types of procedures.  
Materiel and Methods: After approval of the IRB, this observational prospective and 
monocentric study was performed in the urology unit at Rennes university hospital between 
December 2015 and October 2017. All patients scheduled for RARP performed by one 
experienced surgeon were consecutively included. The possibility of discharge was evaluated 
using the PADSS score until patients had a score of 9 or higher allowing their discharge. Risk 
factors of delayed discharge were secondarily assessed 
Results: Ninety-seven patients scheduled for RARP performed by one experienced surgeon 
were consecutively included. Only 1 patient had a PADSS score  9 the day of the surgery 
(day 0). 74% of the patients achieved discharge criteria one day after surgery whereas, 33% 
and 66% of the population was effectively discharged on day 2 and day 3, respectively. 
Patients with a PADSS score  9 at day one experienced significantly less postoperative 
nausea and vomiting than patients with a PADSS score  9 at day 2 or 3 (7% vs 28%, p = 
0.01).  
Conclusion: Outpatient RARP was not feasible in most patients. However, routine discharge 
at day 1 seems conceivable. Improving the management of PONV may even allow outpatient 
management. This progress remains to be confirmed by further studies. 
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Introduction 
 
Prostate cancer (PCa) is the second most common cancer in men behind lung 
cancer with 1,095,000 new cases in worldwide in 2012 1. PCa incidence varies 
widely across the world with the highest rates observed in Australia/New Zealand, 
Northern America, Western and Northern Europe with a rate greater than 80 per 
100,000 1. In the same countries, the mortality decreased in recent years, especially 
in The United States (US) with a decline of 4.3% per year between 1996 and 2005 2. 
This decrease is largely attributed to improvement in PCa treatments. Surgery is one 
of the standard treatments for non-metastatic PCa. During last decades, new surgical 
techniques have been proposed to replace open surgery such as laparoscopic 
surgery and robot-assisted surgery. These two latter technics have been shown to 
reduce respiratory and vascular complications, mortality, blood transfusion and 
length of hospital stay 3. A decrease of surgical site infection was also reported 4. 
Robot-assisted radical prostatectomy (RARP) has become a method of choice, with 
50,000 surgeries performed in 2007 in the US 5. When compared with laparoscopic 
surgery, the proofs of the benefit of RARP are scarce in the literature. A recent 
systematic review found a small improvement in postoperative pain at day 1 and up 
to 1 week after surgery with laparoscopic or RARP versus open radical 
prostatectomy 6. Likewise, a decrease of length of hospital stay was reported with 
RARP when compared with open radical prostatectomy 7.  
Improvements in surgical and anesthetic techniques allow outpatient surgery for 
more and more complex surgeries. It has been particularly developed in colorectal 
surgery 8. In a study published in 2015, 5 cases of colectomy were performed in 
outpatient, no patients were readmitted and all patients were highly satisfied 9. With 
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regard to RARP, only few studies have tested the feasibility of outpatient procedure. 
A very small study (11 patients) published in 2010 compared a group of outpatients 
to a group of inpatients after RARP and showed a comparable postoperative pain 
control rate and overall satisfaction rate in both groups. 10. Patients were highly 
selected in this study. To our knowledge, the feasibility of RARP as an outpatient 
procedure has not been shown in large numbers of patients.  
Therefore, the objective of our study was to evaluate the feasibility of routine 
outpatient management after RARP in a large cohort of patients. 
 
Materials and methods 
 
This feasibility study was an observational, prospective and monocentric study. This 
study was performed in the urology unit at Rennes university hospital between 
December 2015 and October 2017, after approval of the IRB (00010254 – 2016 – 
061). According to the French law, the ethics committee (Comité d’éthique de la 
Société Française d’Anesthésie-réanimation (CERAR)) waived written informed 
consent as it was a non-interventional study. 
Patients 
All RARP performed by one experienced surgeon (SV) on adult patients were 
consecutively included. Non-inclusion criteria were RARP performed by another 
surgeon. Exclusion criterion was the non-compliance with the previously defined 
anesthesia protocol. 
Anesthesia protocol 
Patients did not receive any premedication. Intraoperative protocol associated: i) 
induction with propofol, remifentanil using target controlled intravenous (TCI) 
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anesthesia and cisatracurium, ii) adapted antibioprophylaxis as recommended (11) 
iii) maintenance with sevoflurane, TCI remifentanil and cisatracurium as needed. 
Analgesia and anti-emetic prophylaxis were provided with dexamethasone (8mg, 
single dose), ketamine (bolus 0.2 mg/kg then 0.1 mg/kg/h intra operatively), lidocaine 
(bolus 1.5 mg/kg then 1.5 mg/kg/h intra operatively). At the end of the surgery, 
patients without contraindication received paracetamol (1g), ketoprofen (50mg) and 
nefopam (20mg). Postoperative analgesia associated, morphine titration in post-
anesthesia care unit (PACU) and then, oral ketoprofen (50mg/8h), paracetamol 
(1g/6h), and nefopam (20mg/6h). Oral oxycodone (5mg/4h) was used as rescue 
analgesia. Antiemetic treatment (ondansetron) was prescribed if needed. Liquid and 
food were allowed upon return to the urology unit. Patients were advised to chew 
gum. Adequate thromboprophylaxis was prescribed 12. 
 
Outcome measures 
The main objective of the study was to evaluate the feasibility of outpatient 
management after RARP. The possibility of discharge was evaluated using the 
PADSS score (Post Anesthesia Discharge Scoring System), with 5 criteria (vital 
signs, activity, postoperative nausea and vomiting (PONV), pain, surgical bleeding) 
(annex 1). PADSS score was assessed one a day from D0 (day of surgery) until 
patients had a score of 9 or higher allowing their discharge (13)(14). 
Secondary objectives were the assessment of postoperative ileus duration (defined 
by absence of flatus/stool and the time to first flatus/stool was recorded), quality of 
analgesia (evaluated by cumulative analgesics consumption), and postoperative 
complications. Postoperative complications were defined using the Clavien-Dindo 
classification 15 and included surgical revision, death, unscheduled intensive care unit 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
admission, surgical site infection occurring within 30 days after surgery (purulent 
drainage from the superficial or deep incision; organisms isolated from an aseptically 
obtained culture of fluid or tissue; abscess or other evidence of infection during 
reoperation or radiologic examination, signs or symptoms of infection (pain, redness, 
fever)), pulmonary infection (defined by fever, cough, oxygen requirement and lung 
abnormalities on the chest x-ray) or urinary infection (defined by fever, irritative and 
obstructive urinary function signs (urinary frequency, retention and burning) and urine 
bacteria count 103 ufc/ml)) renal failure (according to KDIGO criteria (16) : increase 
plasma creatinine  3mg/l in 48 hours or increase in plasma creatinine  1.5 times 
the baseline over the last 7 days or diuresis < 0.5 ml/kg/h for 6 hours), stroke 
(defined by clinically evident temporary or permanent new neurologic focal deficit and 
confirmed by a radiologic examination) acute coronary syndrome (defined by chest 
pain with ST-segment modification in an electrocardiogram and elevation of 
troponin), acute limb ischemia (defined by pain, pallor, pulseless, perishing cold, 
paresthesia and paralysis). We also hypothesized that we would be able to identify 
risk factors for prolonged hospitalization (past Day 0). 
 
Data collection 
Aside from demographic data, we also collected the following data during the 
surgery: Duration of surgery, bleeding and number of red blood cells transfused, 
completion of lymph node dissection and/or nerve preservation, intraoperative 
complications (defined by any deviation from the ideal intraoperative course between 
skin incision and skin closure for surgical complications and between induction and 
recovery for anesthetic complications), and use of drains. Postoperative data were 
length of stay in PACU, discharge of PACU after 5:00 pm, cumulative opioid 
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consumption in PACU, cumulative analgesics consumption during hospitalization, 
date of first liquid, first food, first ambulation and peripheral catheter removal, date of 
first flatus or stools, PONV and cumulative ondansetron consumption. Postoperative 
complications, PADSS score, needing of nurse interventions (different from usual 
monitoring defined as follows: heart rate, blood pressure, temperature, pain 
assessment by numerical pain scale, diuresis, aspect of the urine every 6 hours) with 
or with not medical call, medical intervention or deviations to standard protocol, and 
date of discharge (surgeon’s decision) were also recorded. The date of bladder 
catheter’s removal was not part of the data collection as it was systematically 
removed on the sixth postoperative day during an outpatient consultation. 
 
Statistics 
All analyses were performed with SAS version 9.4. and all tests were considered 
statistically significant at p  0.05. Quantitative variables were described as follows: 
n, mean ± standard deviation. For qualitative variables, the size (n) and percentage 
(%) were presented for each category. Comparisons between groups were 
performed as follows: for quantitative variables, patients were compared by a 
Student's test when the distribution follows a normal distribution or by non-parametric 
tests of Mann-Whitney Wilcoxon otherwise; for qualitative variables, patients were 
compared by parametric tests of χ2 or nonparametric Fisher when the number is less 
than 5. 
Results 
Between December 2015 and October 2017, 122 patients who underwent RARP by 
one experienced surgeon (SV) were included. As shown figure 1, 97 patients were 
included in the analysis.   
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The mean age of the population was 62.8  5.5 years. The ASA score was 2 for 62% 
of patients and only 1% had an ASA score of 3. The most common comorbidity was 
high blood pressure (31%). Demographics are described Table 1. The duration of the 
surgery was 2.5h  0.4. Three intraoperative complications were reported: a severe 
bradycardia requiring atropine administration, a difficult intubation, and a minor 
subcutaneous emphysema that did not necessitate the interruption of the procedure 
or conversion. 54% of the patients were discharge from PACU after 5:00pm. 
Intraoperative data are detailed Table 2. 
Postoperative data are described Table 3. Only 1 patient had a PADSS score  9 at 
D0, seventy-two patients had a PADSS score  9 at D1 and 25 patients at D2 or D3. 
While 74% of the patients had discharge criteria one day after surgery, 33% and 66% 
of them was effectively discharged on day 2 and day 3, respectively. There were no 
30-day readmissions. 
First flatus appeared at D0 for only 4% of the patients and at D1 for 76%. The vast 
majority of the patients (99%) walked on D1. Nurses interventions more than usual 
monitoring were needed for 38% of the patients (the most frequent for pain, vagal 
types of adverse reaction or blood spot on bandages). These extra interventions led 
to a change in management compared with the usual protocol in only 16 % of the 
patients. There were very few complications, only two renal failure rapidly resolved 
after IV rehydration. The most frequent complication was PONV (12 %). 
 
When comparing patients with a PADSS score  9 at D1 and patients with a PADSS 
score  9 at D2 or D3, the preoperative data were comparable except for the BMI 
which was significantly higher in patients with PADSS score  9 at D1 than patients 
with PADSS score  9 at D2 or D3 (26.1  3.1 vs 24.1  2.6; p = 0.0046). The 
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intraoperative data were also comparable. Postoperatively, patients with a PADSS 
score  9 at D1 experienced significantly less PONV than patients with a PADSS 
score  9 at D2 or D3 (7%vs 28%, p<0.01). Analgesic consumption was comparable. 
We also observed more nurses intervention in patients with PADSS score  9 at D2 
or 3 (80% vs 24%; p < 0.0001), more medical call (40% vs 10%; p = 0.0015), medical 
interventions (32% vs 4%; p = 0.0007) and more deviations to standard protocol 
(32% vs 11%; p = 0.0260). 
Discussion 
In this study, after a RARP only one patient achieved discharge criteria at D0. 
However, 74% of the patients had discharge criteria at D1 and 26% at D2. 
The International Association for Ambulatory Surgery (IAAS) does not define the 
types of surgery eligible for ambulatory (17). Improvements in surgical and anesthetic 
techniques allow outpatient surgery for many types of surgery. For example, in 
orthopedics, outpatient surgery was described for anterior cervical discectomy with a 
success rate of 90%. Indeed, 27 out of the 30 patients studied were discharged the 
same day of surgery with a satisfaction rate of 9.6/10 (18). Several studies also 
reported cases of total hip arthroplasty in outpatients. For example, den Hartog et al. 
showed that 24 patients out of the 27 studied were discharged the same day of the 
surgery without complications or readmission, the other 3 patients were not 
discharged due to PONV and/or dizziness (19). A retrospective study compared 
63,424 total hip arthroplasty surgeries with a hospital stay of 1 to 5 days with 420 
outpatient total hip replacement surgeries and found no difference in terms of 
complications or readmission (20). In abdominal surgery, fast-track recovery program 
have long been developed and a recent article described 5 patients with a colectomy 
were discharged within 12 hours after the surgery (9).  
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Regarding radical prostatectomy, length of stay after prostatectomy has rapidly 
evolved in the recent years:  a systematic review reported 7.87 days for open 
surgery, 6.09 days for laparoscopic surgery and 3.85 days for RARP in 2014 (21). In 
2016, a study comparing RARP to open surgery reported length of stay as short as 
1.55 days and 3.27 days, respectively 7. Previous publications have already 
evaluated the feasibility of outpatient RARP. In 2010, a first study performed RARP in 
11 outpatients without complications and with an excellent satisfaction score (10). In 
2016, a French case report described the case of a 57-year-old patient who was able 
to be discharged less than 12 hours after surgery (22). A prospective study including 
30 highly selected patients reported that 87% of the patients were discharged the 
same day of the surgery without postoperative complications and with excellent 
patient satisfaction (23). 
In our study, the main risk factor for delayed discharge was PONV. PONV is 
commonly reported after abdominal surgery. Some studies have shown a higher rate 
of PONV in laparoscopic surgery compared to open surgery (24)(25). More recently, 
one study had shown a higher rate of PONV in robotic surgery, with 33% of PONV 
after RARP versus 16% after laparoscopic prostatectomy, probably due to steeper 
head-down position and prolonged pneumoperitoneum (26). In our study, overall 
incidence of PONV was 12%. Our protocol included PONV prophylaxis with 
intraoperative dexamethasone and postoperative ondansetron if needed. The lower 
incidence of PONV observed in our study was probably due to the prophylaxis. 
However, despite this protocol, up to 28% of the patient with delayed discharge 
reported PONV, suggesting intensification of the prophylaxis may be required.  
In our experience, late PACU discharge after 5pm happened in 54% of the patients. 
Late return from PACU preclude any chance of D0 discharge and outpatient 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
management in French institutions. Indeed, according to the French definition of 
outpatient surgery and because of the closing constraints of the outpatient surgery 
department, patients have to leave the hospital before 9:00 pm. However, the 
definition of outpatient surgery varies widely in the literature. In France, the code of 
public health defines outpatient surgery as a hospital stay of less than or equal to 12 
hours not including a night in hospital (27). The IAAS defines true ambulatory surgery 
as a discharge during the time frame of one working day (6 to 8 hours) with no 
overnight stay and ambulatory surgery with extended recovery with a stay for one 
night postoperatively in a hospital facility (overall stay up to 23 hours) (28). However, 
previous studies on outpatient RARP did not specify whether it was true ambulatory 
or an ambulatory surgery with extended recovery, for example, Berger et al. 
compared outpatient and inpatient group after RARP but in the outpatient group, 87% 
of the population were discharge the same day of surgery and the other stayed 
overnight with a mean length of stay of 14h for the outpatient group (23). In our 
study, the PADSS score at D1 was not evaluated in the morning but rather in the 
afternoon. Therefore, it could be considered that most of our patients were likely to 
be ready for discharge within the 24 postoperative hours and were eligible to 
outpatient discharge with extended recovery. 
In order to achieve outpatient RARP, we applied recommendations for enhanced 
recovery after surgery (ERAS). ERAS combines pre-, intra-, and postoperative 
measures adapted to the surgery to counteract or minimize the deleterious effects of 
surgery and/or anesthesia. ERAS was initially implemented in colorectal surgery and 
is now developed for various types of surgeries 8. Guidelines for colorectal surgery 
combine among other things, preoperative information, a reduce preoperative fasting 
(6h for solids and 2h for liquids) with administration of carbohydrate-rich isotonic 
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fluids, intraoperative monitoring fluid administration based, hypothermia and PONV 
prevention and postoperative multimodal analgesia privileging non-opioid drugs, 
adequate thromboprophylaxis, enforced patient mobilization and early oral feeding. 
These guidelines could apply for RARP. However, specific guidelines remain to be 
publish.  Opioid free anesthesia seems to demonstrate a decrease in postoperative 
pain and PONV 29 which could also allow an earlier discharge of patients. In our 
study, preoperative counseling was probably missing and could improve earlier 
discharge when implemented. 
Our study has some limitations. It is an observational and monocentric study. 
However, all patients received a pre-defined standard anesthesia protocol. All RARP 
were performed by a single and experienced surgeon. Discharge was only 
considered on PADSS score and PADSS score may have missed clinical or 
institutional limitation that preclude early discharge. Indeed, items like comfort, 
willingness and/or readiness to go home, fatigue, eating well, ileus, etc…could also 
be determinant for discharge. 
 
In conclusion, discharge at D0 after RARP was not feasible in our study. Discharge 
at D1 was however possible. It is a significant improvement over an effective 
discharge at D3. Reinforcing PONV prophylaxis and institution organization would 
probably allow earlier discharge and probably outpatient management. In this 
context, an opioid free anesthesia could be proposed and needs to be further 
studied. 
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Legend of the figures: 
 
Figure 1: Flow chart 
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Table 1: Preoperative data   
Age  
ASA score 
 1  
62.8  5.5 
 
36 (37%) 
 2  60 (62%) 
 3  
BMI 
1 (1%) 
25.6  3.1 
Diabetes  3 (3%) 
Kidney diseases  2 (2%) 
Respiratory diseases  5 (5%) 
Liver diseases  1 (1%) 
Vascular diseases   3 (3%) 
Coronary diseases  5 (5%) 
High blood pressure  30 (31%) 
Smoking  12 (12%) 
Blood disorders  1 (1%) 
Chronic Platelet antiaggregant 
treatment  
8 (8%) 
Chronic Anticoagulant treatment  1 (1%) 
Patient characteristics are described by mean  standard deviation (SD) 
for quantitative values and n and percentage for qualitative values with n 
global = 97. BMI: Body mass index 
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Table 2: Intraoperative data   
Duration of surgery (h)  
Bleeding more than 500ml  
2.5  0.4 
1 (1%) 
Lymph node dissection  73 (75%) 
Nerve preservation  
 Bilateral  39 (40%) 
 Unilateral  9 (9%) 
Intraoperative complications  
Antibioprophylaxis  
Duration PACU (h)  
3 (3%) 
97 (100%) 
2.6  0.9 
Discharge of PACU after 5:00pm  52 (54%) 
Morphine in PACU (mg)  5.9  5.4 
  
Intraoperative data are described by mean  standard deviation (SD) for 
quantitative values and n and percentage for qualitative values with n 
global = 97. h: hours, mg: milligram 
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Table 3: Postoperative data   
First liquid (h+ PACU discharge)  1.5  1.7 
First food (h+ PACU discharge)  5.6  3.6 
First flatus   
 D0  4 (4%) 
 D1  74 (76%) 
 D2  19 (20%) 
Chewing-gum protocol  40 (41%) 
First ambulation   
 D0  1 (1%) 
 D1  96 (99%) 
Perfusion catheter removal   
 D0  1 (1%) 
 D1  89 (92%) 
 D2  7 (7%) 
Postoperative protocol application  62 (64%) 
Oxycodone consumption (mg)  1.5  3.6 
Ketoprofen consumption (mg)  57.2   80.0 
Paracetamol consumption (g)  4.4  2.0 
Nefopam consumption (mg) 
Postoperative complications (Clavien-Dindo 
classification) 
Grade 1 
Renal failure 
PONV 
Grade 2 
Grade 3 
Grade 4 
Grade 5 
 
20.8  31.1 
 
 
2 (2%) 
12 (12%) 
0 
0 
0 
0 
Postoperative data are described by mean  standard deviation (SD) for 
quantitative values and n and percentage for qualitative values with n 
global = 97. h+ PACU discharge is number of hours after PACU discharge; 
mg: milligram, g : gram 
 
 
 
 
 
